| |
KLSE: NEXGRAM (0096) | NEXGRAM HOLDINGS BHD | ACE : Telco&Media |
Last Price | Today's Change | Day's Range | Trading Volume |
0.045 | 0.00 (0.00%) | 0.045 - 0.05 | 29,608,100 |
Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more. |
Financials
Market Cap: 100 Million
| Latest Audited Result: 31-Jul-2020
| Latest Quarter: 31-Oct-2020 [#1]
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Annual (Unaudited) ( EPS: -2.78, P/E: -1.62 )
| T4Q Result ( EPS: -2.89, P/E: -1.56 )
| Annualized Result ( EPS: -0.48, P/E: -9.41 )
|
Business Performance
Business Performance (By Quarter)
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 0 / 4 | 0.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Positive Profit | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | -17.36% | -8.70% | ||
Average Net Profit Margin | -110.07% | -71.05% |
Business Performance (By Year)
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Years Of Revenue Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Total Positive Profit Years | 0 / 5 | 0.00% | 4 / 10 | 40.00% |
Continuous Years Of Positive Profit | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Years Of Profit Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Years Of Adjusted EPS Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Total Dividend Years | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Years Of Dividend | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Years Of Dividend Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Years Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Average ROE | -21.77% | -7.14% | ||
Average Net Profit Margin | -68.98% | -30.44% |
Key Result
Key Result
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 42,220 | 51,784 | 41,277 | 57,838 | 39,683 |
NP to SH | -64,527 | -10,660 | -61,890 | -12,151 | -31,571 |
Dividend | 0 | - | - | - | - |
Adjusted EPS | -2.89 | -0.48 | -2.78 | -0.54 | -1.42 |
Adjusted DPS | 0.00 | 0.00 | 0.00 | - | - |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
Growth (By Quarter)
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -18.27% | 7.86% | 7.86% | 22.65% | 2.63% |
NP to Owner | 95.53% | -4,077.61% | -4,077.61% | 83.48% | 76.50% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adj. EPS | 95.51% | -4,094.18% | -4,094.18% | 83.41% | 76.41% |
Adj. DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
Growth (By Year)
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 2.28% | 6.39% | -27.00% | 25.45% | 30.49% | -10.47% | -29.25% | 4.02% | -28.63% |
NP to Owner | -4.26% | -104.38% | -431.02% | 82.78% | 66.24% | 12.27% | -182.44% | -96.03% | -409.32% |
Dividend | 0.00% | 0.00% | 0.00% | - % | - % | - % | 0.00% | 0.00% | 0.00% |
Adj. EPS | -4.14% | -104.14% | -430.38% | 82.70% | 66.09% | 11.91% | -182.44% | -96.03% | -409.32% |
Adj. DPS | 0.00% | 0.00% | 0.00% | - % | - % | - % | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
![]() DRwarrant POTENTIAL 6 SEN TODAY $$ as worsening Covid is DAMN GOOD to NEXGRAM business = $$$ During MCO ..no gaming out let , NO Magnum 4D , No TOTO , NO Genting Casino & what not... FURTHER MORE WITH GOVERNMENT STIMULUS MONEY / FUND $$$ - MORE LIQUIDITY IN MARKET SO BURSA/KLSE to be VERY HOT = $$$$$ 21/01/2021 9:26 AM 8dragon Nexgram.... Don't ever dream for the share to go up above 5 cents... Not in this 2 months at least.. 21/01/2021 2:10 PM DRwarrant " I have a dream.....( US M Luther King ) " NEXGRAM to HIT 10 SEN by CNY@Chinese New Year = $$$$$ 21/01/2021 2:36 PM MZM2511 Warren Buffett - "The stock market is device to transfer money from the impatient to the patient" 21/01/2021 3:44 PM OKU_2020 Aydenlutfi@8Dragon... Good bye nexgram. 3cents is coming. Hahahaha 21/01/2021 5:26 PM ++++++++++ YOOOO....smell a rat ( bau tikus) on this cap ayam -holland GN3 ( PN17) Nexgram.... getting worst ,,,no hope smell a rat >> Meaning : sense that something is not right Source: theidioms.com 22/01/2021 11:31 AM MZM2511 OKU_2020 YOOOO....smell a rat ( bau tikus) on this cap ayam -holland GN3 ( PN17) Nexgram.... getting worst ,,,no hope ................................................... Somebody who aims to buy Nexgram @3 sen is smelling rats, but somebody who aims for BOOM in Nexgram's price in near future will smells flowers. He He 22/01/2021 2:07 PM 8dragon Soon everyone will be welcoming and celebrating Nexgram being promoted to GN3... 22/01/2021 2:31 PM 8dragon Nexgram had been talking about mega projects like cyberjaya, angkasa and trx...all ended up in failure... Now talking about vaccine... can it be a reality and success.. let's wait and see 22/01/2021 2:58 PM MZM2511 Soon the color of the eyes of 8dragon and OKU_2020 will be in white because Nexgram will never listed as GN3 company in the near future. He He. 22/01/2021 3:00 PM OKU_2020 8dragon @Soon everyone will be welcoming and celebrating Nexgram being promoted to GN3... 22/01/2021 2:31 PM +++++++++ YOOOO.....already Kena GN3@PN17 ini Cap Ayam -Holland Nexgram 22/01/2021 3:06 PM MZM2511 8dragon Nexgram had been talking about mega projects like cyberjaya, angkasa and trx...all ended up in failure... Now talking about vaccine... can it be a reality and success.. let's wait and see ------------------------------------------------------------ Rafarma is not manages by 8dragon or OKU_2020, those who always in fear of risks and misleading others about a company that they are always keep looking at. Rafarma, the JV partner of VaccineLab is an American company with a great prospects. Okay. Let us wait for the results of the JV. Is it a con job by two con companies or it will be a reality??? I'll take a risks and waiting for the rewards. 22/01/2021 3:15 PM MZM2511 limit_up Someone collecting... ------------------------------------------------ Also there are many potential investors keep waiting to buy @3 sen, and always badmouthing Nexgram to make sure their bad intentions achieved. He He LOL 22/01/2021 3:25 PM MZM2511 @OKU_2020/8dragon/Aydenlutfi. Jual saja kemudian belllahhh.. He He Tak banyak songeh nanti. 22/01/2021 3:42 PM 8dragon The co is going to reward to those who has been waiting @ 3 cents... is just a matter of time.. just wait patiently. Lol 22/01/2021 3:44 PM MZM2511 8dragon The co is going to reward to those who has been waiting @ 3 cents... is just a matter of time.. just wait patiently. Lol ----------------------------------------- If the price reverses to upside without touching low @3 sen, how can "the white eyes" such as 8dragon/OKU_2020/Aydenlutfi can be rewarded. LOL 22/01/2021 3:49 PM MZM2511 @OKU_2020/8dragon/Aydenlutfi. Jual saja kemudian belllahhh.. He He Tak banyak songeh nanti. 22/01/2021 4:01 PM OKU_2020 @8dragon Habis liaw, today close 4 cents.. ++++++++++ Aiyooo Maaa....Gloomy outlook 22/01/2021 4:17 PM SeliparJepon Barang AAA.wait 3 month lagi.Mau kaya tunggu.Hphone kasi picah.Pasword kasi reset.hahhaah 22/01/2021 5:33 PM Monde @Warrant, please support https://aplabworld.com/ APlab in partnership with Tracvirus-UMBI Care (“TUC”) at UKM Medical Molecular Biology Institute (“UMBI”) for walk-in, and drive-thru COVID-19 test. Get tested by doctor for Covid-19 at home or work place. ” Partnering with Tracvirus means APlab has access to combined over 15,000 PCR test a day across various KKM accredited labs throughout Malaysia. “ 22/01/2021 10:59 PM Monde Ministry of Health approved RT-PCR laboratory for COVID-19 includes UKM Medical Molecular Biology Institute (Institut Perubatan Molekul UKM) 22/01/2021 11:03 PM MZM2511 Good news Monde, and good job Nexgram in adding the company's TracVirus and test kits businesses. 22/01/2021 11:52 PM limit_up Bukan saje keluar tanduk, siap tumbuh sayap. Nampaknya sudah mau terbang next week... 23/01/2021 8:24 AM MZM2511 OKU_2020. Warren Buffett - "The stock market is device to transfer money from the impatient to the patient" 23/01/2021 9:03 AM MZM2511 @OKU_2020. Jual sajalah atau belah sajalah. GG dok tunggu syarikat tak ada prospek. He He 23/01/2021 9:06 AM OKU_2020 Beb... Biaq aku jirus ayaq sejuk ( throww cold water ) kat Mamat limit_up yg tengah feeling nii .... So many times already KENA PREQQQ haaa !! siok sendiri daaa... what do you expect from this cap ayam-holland GN3 NexGERAM . 23/01/2021 9:36 AM MZM2511 OKU_2020. Ambo cuba ingat pengalaman lama. Dulu beli Keladi Maju @ 20 sen lebih. Starked, simpan untuk +- 5 tahun. Pernah turun +- 5 sen. Harga dia lama berada lingkungan 10 sen. SATU HARI TU, TIBA-TIBA mencanak dia naik dan jual terus pada harga +- 40 sen, setelah +- 5 tahun menunggu. Antara pengalaman manis menunggu... 23/01/2021 9:50 AM OKU_2020 MZM2511 OKU_2020. Ambo cuba ingat pengalaman lama. Dulu beli Keladi Maju @ 20 sen lebih. Starked, simpan untuk +- 5 tahun. Pernah turun +- 5 sen. Harga dia lama berada lingkungan 10 sen. SATU HARI TU, TIBA-TIBA mencanak dia naik dan jual terus pada harga +- 40 sen, setelah +- 5 tahun menunggu. Antara pengalaman manis menunggu... 23/01/2021 9:50 AM ++++++++++++++ Thanks for the joke...tapi ini kisah benar from demo@MZM2511...yg TER_SEKSA @ AZAB saham tersangkut/starked selama 5 tahun...Degree MD ( Doktor Perubatan ) pun siap 5 tahun Beb ini input bagus for those sifu(s) conducting seminar ( now MCO then webminar).. You know what is Opportunity Cost ( Kos Melepas ) ??...selama 5 tahun tersangkut saham tuu?.. ni bukan 5 hari beb...tapi 5 tahun daaa... Gi ambiq texbook Ekonomi Asas SPM waktu anak anda dah tidorr....tidak pun google jerr lagi copeq jangg oiii...! 23/01/2021 2:03 PM MZM2511 Ambo pernah ngajar ekonomi asas tingkatan 4 dan 5, ajar matrikulasi subjek Ekonomi dan ajar prinsip akaun. Dah lali dah. Tapi lebih baik tanggung kos lepas dari tanggung rugi cut loss. He He 23/01/2021 2:11 PM MZM2511 8dragon Nexgram had been talking about mega projects like cyberjaya, angkasa and trx...all ended up in failure... Now talking about vaccine... can it be a reality and success.. let's wait and see -------------------------------------- Tambahan. Sekadar nak kongsi idea yang saya fahami bahawa rakan JV VaccineLab bukanlah sebuah syarikat con, JV dengan VaccineLab dibuat dengan bersungguh-sungguh oleh sebuah syarikat Listed di NYSE yang dalam proses expansion. Rafarma is in their expansion exercises: 1. They has been merged with BIOCOGENCY LABORATORIES. Source: https://finance.yahoo.com/news/rafarma-closes-biocogency-merger-131500062.html 2. Rafarma Finalizes Acquisition of Laskavy Patents, Prepared as Global Markets Reset Source: https://finance.yahoo.com/news/rafarma-finalizes-acquisition-laskavy-patents-165145871.html 3. Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects Source: https://finance.yahoo.com/news/rafarma-establishes-thailand-corporate-entity-151300760.html 4. Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer Source: https://finance.yahoo.com/news/rafarma-merger-company-bebig-approved-141500701.html 5. Rafarma Inks Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia Source: http://rafarma.si/rafarma-inks-joint-venture-agreement-with-vaccines-lab-sdn-bhd-of-malaysia/ 23/01/2021 3:29 PM MZM2511 Sekadar harapan. Harapan yang disandarkan kepada Rafarma, rakan kongsi JV antara VaccineLab dan Rafarma. Semuanya saya kira berdasarkan bukti yang ada dapat diperoleh. BUKAN SEKADAR ANDAIAN/KENYATAAN KOSONG YANG TANPA FAKTA. 23/01/2021 3:30 PM OKU_2002 @OKU_2020 hari2 cakap NG cop ayam lah, NG GN3 lah tapi menyemak je kat nexgram i3 tak nak keluar buat apa?. Saja nak tau 23/01/2021 7:19 PM SeliparJepon Relax jgn gado2.tomolow operator kasi up sikit.kasi semua happy.TP 0.50 shj.4 bln lagi.hahaha 24/01/2021 9:09 PM Abd Rahim Osman Makan ubat dulu Tido awai Bangun besok... Mana tau jadii KAYA Nexgram tuju langit 24/01/2021 9:44 PM ![]() ![]() |
|